Loading
National Instruments Corp Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 31 Jan 2022.
National Instruments Corp: what insiders have been doing
This page follows insider dealings at National Instruments Corp as filed with SEC (Form 4), a company from the Technology sector based in Austin, United States. The group dates from 1976. The past year has been quiet: not a single insider filing for National Instruments Corp. The previous disclosure was published on 11 October 2023.
Over the whole record (from 2016), the tally stands at 2 purchases and 27 sales.
For comparison within the same sector, see the insider buying recorded at Core Scientific, Inc./tx and Gitlab Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
93
Thresholds
n/a
Buy Volume
€73,527
2 ops. · all time
Sell Volume
€7M
27 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2022FY ended December 2022 · cache
Income statement
RevenueUS$1.4B
Gross profitUS$966.3M68% margin
Net incomeUS$120.2M8.4% margin
Last declaration on 11 October 2023
Declarations93 total
121,775 sharesCommon StockSEC:0001140361-23-047925:0
21,501 sharesCommon StockSEC:0001140361-23-047924:0
150 sharesCommon StockSEC:0001140361-23-047918:0
27,919 sharesCommon StockSEC:0001140361-23-047917:0
248,908 sharesCommon StockSEC:0001140361-23-047928:0
18,560 sharesCommon StockSEC:0001140361-23-047921:0
47,092 sharesCommon StockSEC:0001140361-23-047926:0
21,501 sharesCommon StockSEC:0001140361-23-047919:0
10,477 sharesCommon StockSEC:0001140361-23-047922:0
28,573 sharesCommon StockSEC:0001140361-23-047923:0
16,937 sharesCommon StockSEC:0001140361-23-047927:0
184,813 sharesCommon StockSEC:0001140361-23-047920:0
5,025 shares@ US$59.0070.2% of flowCommon StockSEC:0000935494-23-000071:0
3,494 shares@ US$57.7018.5% of flowCommon StockSEC:0000935494-23-000062:0
29,821 shares@ US$57.97574.7% of flowCommon StockSEC:0000935494-23-000060:0
5,037 shares@ US$58.05546.2% of flowCommon StockSEC:0000935494-23-000058:0
150 shares@ US$45.901.1% of flowCommon StockSEC:0000935494-23-000045:0
503 shares@ US$58.2317.8% of flowCommon StockSEC:0000935494-23-000051:0
124 shares@ US$45.900.2% of flowCommon StockSEC:0000935494-23-000047:0
9,479 sharesCommon StockSEC:0000935494-23-000049:0
2,155 shares@ US$58.2329.8% of flowCommon StockSEC:0000935494-23-000038:0
7,852 shares@ US$58.2340.9% of flowCommon StockSEC:0000935494-23-000041:0
3,719 shares0Common StockSEC:0000935494-23-000024:0
3,719 shares0Common StockSEC:0000935494-23-000028:0
3,719 shares0Common StockSEC:0000935494-23-000020:0
25 of 93 declarations
About National Instruments Corp
From a market-positioning standpoint, NI has long been viewed as a premium brand in automated test because of its integrated ecosystem and strong engineering credibility. Emerson stated that NI served about 35,000 customers and generated $1.66 billion of revenue in 2022, highlighting the scale of the platform before integration. Recent developments have centered on Emerson’s continued investment in NI’s roadmap: in 2024 Emerson reaffirmed support for core NI products such as LabVIEW and TestStand and showcased AI-related enhancements at NI Connect. For investors, NATI should therefore be understood as a specialized technology franchise, now part of Emerson, with exposure to secular demand for intelligent test automation, product validation, and digital manufacturing workflows in the United States and globally.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
